Moreover, in survival analysis, NUCB1 and IRF4 showed significant p-values and HR > 2, while ANXA5 was not statistically significant with HR = 1.3 for DLBCL survival (Figure 4). The gene discussed is ANXA5; the disease is diffuse large B-cell lymphoma.